Synthesized peptide derived from human C/EBP-α (Phospho Ser193)

This antibody detects endogenous levels of Human,Mouse,Rat C/EBP-α (Phospho Ser193).The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):HAsPA

CEBPA

C/EBP-α (Phospho Ser193)

CCAAT/enhancer-binding protein alpha ;
C/EBP alpha ;

function:C/EBP is a DNA-binding protein that recognizes two different motifs: the CCAAT homology common to many promoters and the enhanced core homology common to many enhancers.,similarity:Belongs to the bZIP family.,similarity:Belongs to the bZIP family. C/EBP subfamily.,similarity:Contains 1 bZIP domain.,subunit:Binds DNA as a dimer and can form stable heterodimers with C/EBP beta and gamma. Interacts with UBN1. Interacts with HBV protein X.,

urea cycle, negative regulation of transcription from RNA polymerase II promoter, in utero embryonic development,liver development, placenta development, embryonic placenta development, immune system development, leukocyte differentiation, myeloid leukocyte differentiation, generation of precursor metabolites and energy, transcription,transcription, DNA-dependent, regulation of transcription, DNA-dependent, regulation of transcription from RNA polymerase II promoter, transcription from RNA polymerase II promoter, mitochondrion organization, negative regulation of cell proliferation, embryonic development ending in birth or egg hatching, negative regulation of biosynthetic process, positive regulation of biosynthetic process, regulation of specific transcription from RNA polymerase II promoter, positive regulation of specific transcription from RNA polymerase II promoter, positive regulation of macromolecule biosynthetic process, negative regulation of macromolecule biosynthetic process, positive regulation of macromolecule metabolic process, negative regulation of macromolecule metabolic process, positive regulation of gene expression, negative regulation of gene expression, negative regulation of transcription, cytokine-mediated signaling pathway, urea metabolic process, developmental maturation, hemopoiesis, myeloid cell differentiation, macrophage differentiation, respiratory tube development, lung development, negative regulation of cellular biosynthetic process, positive regulation of cellular biosynthetic process, regulation of gene-specific transcription, RNA biosynthetic process, tube development, regulation of cell proliferation, chordate embryonic development, positive regulation of gene-specific transcription, cellular amide metabolic process, amide biosynthetic process, nitrogen compound biosynthetic process, fat cell differentiation, regulation of transcription, negative regulation of transcription, DNA-dependent, positive regulation of transcription, DNA-dependent, negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process, positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process, positive regulation of transcription, positive regulation of transcription from RNA polymerase II promoter, cell maturation, hemopoietic or lymphoid organ development,embryonic organ development, brown fat cell differentiation, negative regulation of nitrogen compound metabolic process, positive regulation of nitrogen compound metabolic process, regulation of RNA metabolic process, negative regulation of RNA metabolic process, positive regulation of RNA metabolic process, respiratory system development,